Journal of Clinical Toxicology

Journal of Clinical Toxicology
Open Access

ISSN: 2161-0495

+44 1478 350008

Case Report - (2011) Volume 1, Issue 3

Neem Extract Poisoning as a Cause of Renal Tubular Acidosis

Jonathan Brett1*, Rohan Beresford1, Jacob Sevastos1 and Richard Day2
1Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Victoria St, Darlinghurst, NSW 2010, Australia
2University of New South Wales, University of New South Wales and St Vincent’s Hospital, Sydney, Australia
*Corresponding Author: Jonathan Brett, Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Victoria St, Darlinghurst, NSW 2010, Australia, Tel: 0450757290, Fax: 02-8382 2724 Email:

Introduction

Neem is the name used to describe a heterogenous group of compounds derived from the tree Azadirachia indica, an evergreen of the mahogany family Melaceae and endemic to the Indian subcontinent and other tropical and subtropical areas. It is also known as India Lilac or margosa tree and more colloquially as ‘Panacea for all diseases’ and ‘Village Pharmacy’. Virtually every part of the tree including the leaf, bark, flower, fruit, seed and gum have been processed for use as soil fertilizer, insecticide, dye, wax, fuel, lubricant, soap, spermicide and in traditional medicine [1].

There are reports of Neem extract causing acute tubular necrosis [2] but we are unaware of any reports describing renal tubular acidosis (RTA) associated with Neem. We report a 51-year-old Solomon Islander presenting with RTA, toxic encephalopathy, hepatotoxicity, anemia and coagulopathy after ingesting large quantities of Neem extract. The patient underwent 4 days of continuous veno-venous hemodialysis (CVVDH) before making a full recovery to discharge 15 days later.

Case Report

Mr FA with diet controlled diabetes and hypertension was flown from the Solomon Islands to a Sydney hospital after being admitted to hospital 3 days earlier with confusion thought to be due to ‘possible plasmodium falciparum’. Treatment had been commenced with Riamet (arthemeter + lumefantrine).

FA was unable to give a coherent history on arrival in Sydney and was afebrile but clinically dehydrated. His heart rate (HR) was 90 beats per minute, blood pressure 135/66, respiratory rate 26 and oxygen saturation 100% on room air. His 12 lead ECG was unremarkable.

His initial arterial blood gas (ABG) on room air revealed a metabolic acidosis with raised lactate and increased anion gap (Table 1). Interestingly he was hypokalemic in the context of mild renal impairment. His urine was alkaline despite a significant anion gap, suggesting a diagnosis of type 1 (distal) renal tubular acidosis. Urgent blood films and immunochromatography were negative for malaria.His total white cell count was normal but he had lymphopaenia and his CRP was raised at 66.7 mg/L. His chest X-ray and computerized tomography (CT) brain were unremarkable.

  10/09/011 (venous) 12/09/11 (arterial) 15/09/11 (arterial) Units
pH 7.25 7.41 7.44  
pO2 34 85 95 mmHg
pCO2 26 26 27 mmHg
HCO3 11 16 18 mmol/L
Lactate 2.8 4.7 2.6 mmol/L

Table 1:Blood gas results, all on Fi02 of 0.29

Antimalarials were ceased and sodium bicarbonate 8.4%, 100ml (100mequ) administered four hourly. Hartman’s solutions’ and parenteral potassium was administered. On the second day of his admission he became drowsier and given his decreasing plasma bicarbonate and worsening acidosis he was transferred to intensive care for 4 days of CVVHD.

Normocytic anemia without a reticulocytosis to a nadir of Hb of 81g/L on day 4 of his admission indicated possible bone marrow suppression (Table 2). This coincided with a rise in the prothrombin (21s) and activated partial thromboplastin times (42s) with a relatively low fibrinogen (0.8g/L) and raised D-dimer (1.36mg/L), raising the possibility of DIC.

  10/09/11 14/09/11 21/09/11 Range Units
Hb 156 83 108 130-180 Units
Plt 185 45 217 150-400 g/L
Neutrophils 7.8 3.8 6.6 2.0-7.5 10x9/L
Lymphocytes 0.5 0.5 1.1 1.5-4.0 10x9/L

Table 2: Blood indices

His liver function tests also became markedly abnormal in a predominantly cholestatic pattern, with his GGT, ALP and bilirubin peaking on day 8-post admission (Table 3).

  10/09/11 18/09/11 21/09/11 Range Units
Sodium 131 136 135 137-146 mmol/L
Potassium 2.9 3.7 4.3 3.5-5.0 mmol/L
Chloride 101 100 96 95-110 mmol/L
Bicarbonate 9 20 30 24-31 mmol/L
Creatinine 110 90 97 60-12 umol/L
Urea 14 6.5 6.8 3.0-8.5 mmol/L
Albumin 36 41 40 36-52 g/L
Bilirubin 14 48 24 0-18 umol/L
ALT 49 229 248 0-30 U/L
AST 21 164 125 0-30 U/L
ALP 53 407 312 30-100 U/L
GGT 28 1330 836 0-35 U/L

Table 3: Plasma electrolytes, creatinine, urea and liver function tests.

On day 5, blood ammonia concentration was elevated at 108μmol/L and a ‘metabolic screen’ to exclude metabolic encephalopathy was performed. Urinary and plasma amino acids and his blood organic acid profile were suggestive of multiple acyl-CoA dehydrogenase deficiency.

On the fifth day of admission his confusion had almost completely resolved and a more thorough history revealed consumption of large quantities of Neem extract imported from India (200ml three times per day) over the preceding 3 months in order to treat his diabetes. It was unclear which part of the A indica tree this extract was from.

His urine and serum levels of lead, cadmium, mercury and copper were tested and unremarkable.

On day 5 he was transferred back to the ward and from day 8 to day 20 his biochemical and haematological parameters improved. He returned to the Solomon Islands on day 21 post admission fully recovered.

Discussion

It is highly likely that Mr FA was poisoned with Neem extract causing distal RTA, hepatitis with metabolic encephalopathy and disturbances in hematopoiesis and coagulation. Riamet is not known to be associated with renal toxicity [3].

In traditional medicine, extracts of A indica from the seed, to make ‘margosa’ or ‘neem’ oil and from the leaf, have been used to treat a myriad of diseases from leprosy to helminthic infections. The potential medicinal properties have been reviewed by van der Nat et al in their ethnopharmacognostical survey [1]. The main active compounds in Neem oil are limonoids, including azadirachtin and particular attention has been directed to the antimalarial activity of compounds such as gedunin and nimbolide [4, 5]. Animal and human studies of orally administered A indica seed and leaf extracts have shown hypoglycemic effects in non-diabetic and type 2 diabetic patients similar to sulphonylurea drugs, although there is controversy regarding the mechanism of action [6,7]

There are numerous human case reports as well as animal studies of Neem extract revealing toxic effects including toxic encephalopathy and status epilepticus [8,9], Reye’s like syndrome of microvesicular fatty liver [10,11] and metabolic acidosis [12]. Almost all of these case reports are from children receiving Neem oil and the case fatality rate was high. In vitro experiments have demonstrated a possible mechanism for Neem oil toxicity namely uncoupling of mitochondrial oxidative phosphorylation. These extracts have also been found to decrease intramitochondrial levels of acetyl CoA in rat liver mitochondria, which may explain the metabolic screen results in this patient [13].

Contamination of Neem extracts with either solvents used during extraction or aflatoxins [10] may cause acute toxicity. Also, contamination with heavy metals such as lead and cadmium [14] is also widely reported in Ayurvedic medicines and renal dysfunction may result. There is only limited systematic toxicology data, almost exclusively from animal studies, regarding the safety of neem derived products [15].

A indica is very similar in appearance and often grows in proximity to the Chinaberry tree (Melia azedarach), all parts of which are extremely poisonous to mammals and so there is also a risk of toxicity through mistaken identity [16].

Proximal RTA has been reported to occur with the intake of Chinese herbs [17,18], often containing aristolochic acid. Distal RTA is a documented complication of amphotericin B, lithium carbonate and toluene exposure [19] but to our knowledge this is the first documented case of distal RTA caused by a traditional herbal medicine .

References

  1. Van der Nat J M, WG van der Sluis, KTD de Silva, RP Labadie (1991) Ethnopharmacognostical survey of Azadirachta indica A. Juss (Meliaceae) J Ethnopharmacol 35: 1-24.
  2. Kadiri S, A Arije and BL Salako (1999) Traditional herbal preparations and acute renal failure in south west Nigeria. Trop Doct 29: 244-246.
  3. Falade C and C Manyando (2009) Safety profile of Coartem: the evidence base. Malar J 8: 6.
  4. Khalid SA, H Duddeck, Gonzalez-Sierra M (1989) Isolation and characterization of an antimalarial agent of the neem tree Azadirachta indica. J Nat Prod 52: 922-926.
  5. Rochanakij S, Thebtaranonth Y, Yenjai C, Yuthavong Y (1985) Nimbolide, a constituent of Azadirachta indica, inhibits Plasmodium falciparum in culture. Southeast Asian J Trop Med Public Health 16: 66-72.
  6. Shukla RC, S Singh and Bhandari CR (1973) Preliminary Clinical Trials on antidiabetic actions of Azadirachta indica. Medicine and Surgery 13: 11-12.
  7. Dixit VP, R Sinha and R Tank (1986) Effect of Neem seed oil on the blood glucose concentration of normal and alloxan diabetic rats. J Ethnopharmacol 17: 95-98.
  8. Lai SM, KW Lim and HK Cheng (1990) Margosa oil poisoning as a cause of toxic encephalopathy. Singapore Med J 31: 463-465.
  9. Dhongade RK, SG Kavade and RS Damle (1982) Neem oil poisoning. Indian Pediatr 2008 45: 56-57.
  10. Sinniah D et al. Reye-like syndrome due to margosa oil poisoning: report of a case with postmortem findings. Am J Gastroenterol 77: 158-161.
  11. Sinniah R, Sinniah D, Lam-San Chia, G Baskaran (1989) Animal model of margosa oil ingestion with Reye-like syndrome. Pathogenesis of microvesicular fatty liver. J Pathol 159: 255-264.
  12. Iyyadurai R , V Surekha, Sowmya S, Benny PW and KG Gopinath (2010) Azadirachtin poisoning: a case report. Clin Toxicol (Phila) 48: 857-858.
  13. Koga Y, Yoshida I, Kimura A, Yoshino M, Yamashita F, Sinniah D, et al. (1987) Inhibition of mitochondrial functions by margosa oil: possible implications in the pathogenesis of Reye's syndrome. Pediatr Res 22: 184-187.
  14. Vasudevan T (2009) Occurance if high levels of cadmium, mercury and lead in medicinal plants of India. Pharmacognosy 5: 15-18.
  15. Boeke SJ , Marelle G B, Gerrit M A, Joop JA , Arnold VH, et al. (2004) Safety evaluation of neem (Azadirachta indica) derived pesticides. J Ethnopharmacol 94: 25-41.
  16. Phua DH ,Wei JT, Jiin G, Jou FD, Chen CY (2008) Human Melia azedarach poisoning. Clin Toxicol (Phila) 46: 1067-1070.
  17. Lee CT, Mai S W, Kang L and Kuo TH (1999) Renal tubular acidosis, hypokalemic paralysis, rhabdomyolysis, and acute renal failure--a rare presentation of Chinese herbal nephropathy. Ren Fail 21: 227-230.
  18. Kazama I, Mitsunobu M, Mari M, Michiko S, Ryo H, et al (2004) Adult onset Fanconi syndrome: extensive tubulo-interstitial lesions and glomerulopathy in the early stage of Chinese herbs nephropathy. Clin Exp Nephrol 8: 283-287.
  19. Patel R, Benjamin J Jr (1986) Renal disease associated with toluene inhalation. J Toxicol Clin Toxicol 24: 213-223.
Citation: Brett J, Beresford R, Sevastos J, Day R (2011) Neem Extract Poisoning as a Cause of Renal Tubular Acidosis. J Clinic Toxicol 1:112.

Copyright: © 2011 Brett J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top